Clinical trial · Interventional
Evaluation of Surgical Excision of Cardiophrenic Lymph Nodes in Patients With Advanced Ovarian Cancer
NCT03235648CI-TRIAL-00028858unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evaluation of surgical excision of cardiophrenic lymph nodes in patients with advanced ovarian cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| cardiophrenic lymph nodes resection | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- cardiophrenic nodes excision in ovarian cancer
- description
- We are going to evaluate the comorbidites and impact of cardiophrenic lymph nodes excision in cases of advanced ovarian cancer with positive cardiophrenic lymph nodes
- interventionNames
- Procedure: cardiophrenic lymph nodes resection
Primary outcomes (1)
- measure
- number of CPN retrieved/pathological nodes
- timeFrame
- up to 3 years
- description
- correlation of radiological active lymph nodes with pathological findings
Secondary outcomes (1)
- measure
- Progression free survival
- timeFrame
- up to 2 years following the end of study
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion criteria * Ovarian cancer patient (FIGO stage III-IV) * Preoperative CT showing CPLN with short axis diameter \> 5mm. * Anathestically fit patient (ASA score I or II). * Accepted pulmonary function test. * Patient who received neoadjuvant chemotherapy or recurrent cases may be enrolled * Written informed consent. * Achievement of optimal cytoreduction intra-abdominal( No residual disease more than 1 cm ) Exclusion Criteria: * Anathestically unfit patient * Unresectable disease * Patient refusal * No detected CPLN by preoperative radiology
References
Publications (0)
Data not yet available
No reference posted for this study.